Navigation Links
ReBuilder Medical Technologies, Inc. Announces Agreement with Internet Marketer Helio Health; Anticipates 12% Additional Profit
Date:10/11/2007

nufacturer of medical devices and innovative technologies founded by world-renowned medical device inventor David B. Phillips, Ph.D. The company's flagship product is its FDA registered ReBuilder System(R), used for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) that depend on prescription drugs with powerful side effects, the ReBuilder System(R) is a portable, battery-powered medical product that provides a unique, non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.

ReBuilder Medical Technologies, Inc. also manufactures the Phillips Molluscum Treatment System(TM) for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum pathogen without side effects. The company is currently performing research and development on a number of other products as well.

ReBuilder Medical Technologies, Inc. is located in Charles Town, WV. CEO, Dr. David Phillips, Ph.D. is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System, which is used for the early detection of breast cancer, and the AcuPen, a hand-held device that provides the benefits of acupuncture without the use of needles.

More information on ReBuilder Medical Technologies, Inc. and its products can be found at: http://www.rebuildermedical.com.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limit
'/>"/>

SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. Teens turning to Internet for medical queries
3. Robots craft medical history
4. NBE to conduct test for medical students from abroad
5. Air pollution combined with greater medical needs
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Children! Protecting them from medical mistakes
8. More information sought by patients on medical errors
9. SARS necessitates medical masks
10. Meditation Works Medically
11. Sleep Disorders Could Indicate Other Medical Problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
(Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
(Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
(Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
...uters all over the world could help to tackle one ...installation of a specialized software.// Africa@...ropéenne pour la Recherche Nucléaire - the Europea...- lets volunteers download the software that crunc...
...leaders here Sunday set a series of guidelines for...ng a document on the issue.// "A vigorous respons...g cause of death worldwide, is essential to global...l-being of the world's population," the leaders sa...
... for information technology to support improvement...eral practice, according to studies published// in...lia (MJA). The two studies both looked into how m... more importantly, what they use their computer fo...
...d that the billions of pounds being spent on hospi...plans for the patterns of care.// The report has ...phants", huge hospitals that would take 30 years t...the future of healthcare lay with smaller, flexibl...
Other Medicine News:Health News:Africa Set to Control Malaria Using Specialized Software 2Health News:IT for General Practitioners 2
(Date:10/8/2008)...N, France, Oct. 8 /- Vical Incorporat...linical data and new nonclinical data,demonstratin...broadly,applicable in DNA- and protein-based infec...ccines. Alain P. Rolland, Pharm.D., Ph.D., Vical,s...l present the data today,Wednesday, October 8, at...
(Date:10/7/2008)...NT, Mich., Oct. 7 /- McLaren Health C...ring some of the world,s leading medical,minds to ... breast and,gastrointestinal cancer treatments. Th...CI, was organized by McLaren,s Sukamal Saha, M.D.,...n sentinel node mapping for,colorectal cancer has ...
(Date:10/7/2008)...ults of FLEXX Trial Presented at the Osteoarthriti...ress, PARSIPPANY, N.J., Oct. 7 /- Fe...lts from the FLEXX Trial of Osteoarthritis of the,...ate), a highly pure,non-avian high molecular weigh... is superior to intra-articular saline (IA-saline)...
(Date:10/7/2008)...NNA, Va., Oct. 7 /- CEL-SCI... has entered into a Material Transfer,Agreement (M...l Center,(NIHCC) and the laboratory of Dr. Frances...r basis of changes to the tumor microenvironment,c...ncola is the Chief of,the Infectious Disease and I...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana 4233 1BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana 4233 2BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana 4233 3Trubion Initiates Phase 1 2 Study of TRU 016 in CLL Announces Next Generation Product Candidate for RA and Provides Product Pipeline Update 1607 1Trubion Initiates Phase 1 2 Study of TRU 016 in CLL Announces Next Generation Product Candidate for RA and Provides Product Pipeline Update 1607 2Trubion Initiates Phase 1 2 Study of TRU 016 in CLL Announces Next Generation Product Candidate for RA and Provides Product Pipeline Update 1607 3Trubion Initiates Phase 1 2 Study of TRU 016 in CLL Announces Next Generation Product Candidate for RA and Provides Product Pipeline Update 1607 4Trubion Initiates Phase 1 2 Study of TRU 016 in CLL Announces Next Generation Product Candidate for RA and Provides Product Pipeline Update 1607 5FDA Probing Possible Link Between Asthma Drug and Suicide Risk 15339 1FDA Probing Possible Link Between Asthma Drug and Suicide Risk 15339 2FDA Probing Possible Link Between Asthma Drug and Suicide Risk 15339 3Insights on Paying for Boomers Care Needs in 20 40 Years Helped by New Report 15337 1Insights on Paying for Boomers Care Needs in 20 40 Years Helped by New Report 15337 2Insights on Paying for Boomers Care Needs in 20 40 Years Helped by New Report 15337 3Insights on Paying for Boomers Care Needs in 20 40 Years Helped by New Report 15337 4Insights on Paying for Boomers Care Needs in 20 40 Years Helped by New Report 15337 5
...p; Tolerability Profile,in Subjects with Type 2 Di...2007 /PRNewswire-FirstCall/ -- Phase III data,pres...can Diabetes,Association demonstrated that saxagli...4) in development by Bristol-Myers,Squibb Company ...xhibited a statistically significant improvement i...
... 2007 - Columbia,Laboratories, Inc. (NASDAQ: CBRX)...completed multi-dose pharmacokinetic study of,vagi... developing,to prevent and treat dysmenorrhea., Th...n blood,levels associated with the Company,s bioad... strengths over multiple doses. The cohort,was ran...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Columbia Laboratories Reports Positive Results from Multi-dose,Pharmacokinetic Study of Vaginally-administered Lidocaine 2Columbia Laboratories Reports Positive Results from Multi-dose,Pharmacokinetic Study of Vaginally-administered Lidocaine 3
Detection of antibodies to Malaria in Human whole blood.
Paracheck Pf is a two site sandwich immunoassay for the detection of P. falciparum specific histidine rich protein 2 (Pf HRP-2) in whole blood samples.
This is an antigen-capture assay intended for the detection of histidine-rich protein ll (PfHRP-ll), which is released from Malaria-infected red blood cells.
The Malaria Combo Test is a rapid test for the qualitative detection of Plasmodium falciparum and / or Plasmodium vivax , Plasmodium ovale and Plasmodium malariae antigen in whole blood. This
Medicine Products: